COGOLLI P.; TESTAFERRI L.; TINGOLI M.; TIECCO M., J. ORG. CHEM., 1979, 44, NO 15, 2636-2642
作者:COGOLLI P.、 TESTAFERRI L.、 TINGOLI M.、 TIECCO M.
DOI:——
日期:——
IAP BIR DOMAIN BINDING COMPOUNDS
申请人:Laurent Alain
公开号:US20090192140A1
公开(公告)日:2009-07-30
Disclosed herein is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I:
or a prodrug, or a pharmaceutically acceptable salt, or labeled with a detectable label or an affinity tag thereof; wherein R
1
, R
1a
, R
100
, R
100a
, R
2
, R
200
, W, B, and W
1
are defined herein. Also disclosed are methods of using compounds of Formula I to treat proliferative disorders such as cancer.
IAP BIR domain binding compounds
申请人:Laurent Alain
公开号:US20120195915A1
公开(公告)日:2012-08-02
Disclosed herein is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I:
or a prodrug, or a pharmaceutically acceptable salt, or labeled with a detectable label or an affinity tag thereof; wherein R
1
, R
1a
, R
100
, R
100a
, R
2
, R
200
, W, B, and W
1
are defined herein. Also disclosed are methods of using compounds of Formula I to treat proliferative disorders such as cancer.